Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provoked a pandemic of acute respiratory disease, namely coronavirus disease 2019 (COVID-19). Currently, effective drugs for this disease are urgently warranted. Anisodamine is a traditional Chinese medicine that is predicted as a potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wei, Kong, Ni, Liu, Meng-Zhen, Han, Ting, Xu, Jun-Feng, Liu, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098399/
https://www.ncbi.nlm.nih.gov/pubmed/35636257
http://dx.doi.org/10.1016/j.bbrc.2022.05.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098399/
https://www.ncbi.nlm.nih.gov/pubmed/35636257
http://dx.doi.org/10.1016/j.bbrc.2022.05.024

Ejemplares similares